Peter Vaillancourt

1.2k total citations
22 papers, 491 citations indexed

About

Peter Vaillancourt is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Vaillancourt has authored 22 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Vaillancourt's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Liver physiology and pathology (4 papers). Peter Vaillancourt is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Liver physiology and pathology (4 papers). Peter Vaillancourt collaborates with scholars based in United States, Greece and Israel. Peter Vaillancourt's co-authors include Joonho Choe, Michael R. Botchan, Arne Stenlund, Chaofeng Zheng, Li Xu, Denise L. Wyborski, John C. Bauer, Suntara Cahya, Jack S. Remington and Fausto G. Araujo and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Virology.

In The Last Decade

Peter Vaillancourt

22 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Vaillancourt United States 11 234 119 116 116 109 22 491
Matthias Schroff Germany 16 306 1.3× 115 1.0× 125 1.1× 316 2.7× 30 0.3× 39 685
Nels E. Pederson United States 13 317 1.4× 444 3.7× 75 0.6× 144 1.2× 116 1.1× 20 749
Bertram T. Ober United States 12 222 0.9× 113 0.9× 96 0.8× 642 5.5× 173 1.6× 16 921
Manfred Wirth Germany 13 424 1.8× 73 0.6× 46 0.4× 86 0.7× 42 0.4× 22 624
Ryozaburo Mukai Japan 13 138 0.6× 139 1.2× 105 0.9× 229 2.0× 49 0.4× 31 528
Hazel Welch United Kingdom 12 211 0.9× 255 2.1× 118 1.0× 92 0.8× 30 0.3× 17 609
Barry Kriegsman United States 7 438 1.9× 71 0.6× 109 0.9× 296 2.6× 86 0.8× 9 733
Martha C. Zúñiga United States 15 418 1.8× 114 1.0× 65 0.6× 381 3.3× 93 0.9× 21 860
Pedro Paz United States 13 559 2.4× 348 2.9× 92 0.8× 384 3.3× 119 1.1× 16 1.0k
Stacia Phillips United States 12 312 1.3× 263 2.2× 128 1.1× 106 0.9× 20 0.2× 27 711

Countries citing papers authored by Peter Vaillancourt

Since Specialization
Citations

This map shows the geographic impact of Peter Vaillancourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vaillancourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vaillancourt more than expected).

Fields of papers citing papers by Peter Vaillancourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vaillancourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vaillancourt. The network helps show where Peter Vaillancourt may publish in the future.

Co-authorship network of co-authors of Peter Vaillancourt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vaillancourt. A scholar is included among the top collaborators of Peter Vaillancourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vaillancourt. Peter Vaillancourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benschop, Robert J., Jay Tuttle, Lin Zhang, et al.. (2022). The anti–SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination. Science Translational Medicine. 14(655). eabn3041–eabn3041. 20 indexed citations
2.
Crisp, Melissa, Nicole L. Kallewaard, Robert J. Benschop, et al.. (2022). The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination. UNC Libraries. 1 indexed citations
3.
Zhang, Lin, Michael Dougan, Peter Chen, et al.. (2021). Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together. Frontiers in Immunology. 12. 790469–790469. 14 indexed citations
4.
Vathiotis, Ioannis, Jon Zugazagoitia, Konstantinos N. Syrigos, et al.. (2021). Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer. Cancers. 13(5). 1024–1024. 8 indexed citations
5.
Peng, Sheng-Bin, Xiaoyi Zhang, Donald C. Paul, et al.. (2016). Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies. PLoS ONE. 11(3). e0150585–e0150585. 50 indexed citations
6.
Parekh, Bhavin S., E. Berger, Suntara Cahya, et al.. (2012). Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay. mAbs. 4(3). 310–318. 76 indexed citations
7.
Zeng, Wei, Lei Yan, Victoria L. Peek, et al.. (2012). Abstract 2734: c-Met antibody LY2875358 (LA480) shows differential antitumor effects in non-small cell lung cancer. Cancer Research. 72(8_Supplement). 2734–2734. 5 indexed citations
8.
Peek, Victoria L., Wei Zeng, Lei Yan, et al.. (2012). Abstract 2738: c-Met antibody LY2875358 (LA480) has pre-clinical enhanced efficacy with gastric cancer standard-of-care in vitro and in vivo. Cancer Research. 72(8_Supplement). 2738–2738. 4 indexed citations
9.
Zeng, Wei, Mark Uhlik, Jonathan Stewart, et al.. (2010). 228 LA480, a bivalent humanized monoclonal c-Met antibody, inhibits tumor growth through an anti-proliferative mechanism. European Journal of Cancer Supplements. 8(7). 74–75. 2 indexed citations
10.
Vaillancourt, Peter & Katherine A. Felts. (2003). Retroviral Delivery of the Ecdysone‐Regulatable Gene Expression System. Biotechnology Progress. 19(6). 1750–1755. 3 indexed citations
11.
Felts, Katherine A., et al.. (2002). Functional Cloning Using pFB Retroviral cDNA Expression Libraries. Molecular Biotechnology. 22(1). 25–32. 3 indexed citations
12.
Wyborski, Denise L., John C. Bauer, & Peter Vaillancourt. (2001). Bicistronic Expression of Ecdysone-Inducible Receptors in Mammalian Cells. BioTechniques. 31(3). 618–624. 18 indexed citations
13.
Vaillancourt, Peter, et al.. (2000). [22] Affinity purification of recombinant proteins fused to calmodulin or to calmodulin-binding peptides. Methods in enzymology on CD-ROM/Methods in enzymology. 326. 340–362. 28 indexed citations
14.
Wyborski, Denise L., John C. Bauer, Chaofeng Zheng, Katherine A. Felts, & Peter Vaillancourt. (1999). AnEscherichia coliExpression Vector That Allows Recovery of Proteins with Native N-Termini from Purified Calmodulin-Binding Peptide Fusions. Protein Expression and Purification. 16(1). 1–10. 14 indexed citations
15.
16.
Vaillancourt, Peter, et al.. (1997). Recovery of Polypeptides Cleaved from Purified Calmodulin-Binding Peptide Fusion Proteins. BioTechniques. 22(3). 451–453. 10 indexed citations
17.
Vaillancourt, Peter, et al.. (1992). A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter. Journal of Virology. 66(12). 7319–7327. 2 indexed citations
18.
Vaillancourt, Peter, Timothy Nottoli, Joonho Choe, & Michael R. Botchan. (1990). The E2 transactivator of bovine papillomavirus type 1 is expressed from multiple promoters. Journal of Virology. 64(8). 3927–3937. 19 indexed citations
19.
Choe, Joonho, Peter Vaillancourt, Arne Stenlund, & Michael R. Botchan. (1989). Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs. Journal of Virology. 63(4). 1743–1755. 120 indexed citations
20.
Vaillancourt, Peter, et al.. (1983). Identification of an antigen-specific immunoglobulin M antibody associated with acute Toxoplasma infection. Infection and Immunity. 41(2). 683–690. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias Schroff Breakdown of academic impact, for papers by Nels E. Pederson Breakdown of academic impact, for papers by Bertram T. Ober Breakdown of academic impact, for papers by Manfred Wirth Breakdown of academic impact, for papers by Ryozaburo Mukai Breakdown of academic impact, for papers by Hazel Welch Breakdown of academic impact, for papers by Barry Kriegsman Breakdown of academic impact, for papers by Martha C. Zúñiga Breakdown of academic impact, for papers by Pedro Paz Breakdown of academic impact, for papers by Stacia Phillips
Rankless by CCL
2026